Author's Reply to the correspondence: ECIL-10 guidelines for COVID-19 should take convalescent plasma into proper consideration by Focosi et al.

Saved in:
Bibliographic Details
Title: Author's Reply to the correspondence: ECIL-10 guidelines for COVID-19 should take convalescent plasma into proper consideration by Focosi et al.
Authors: Cesaro S; Pediatric Haematology Oncology, Department of Mother and Child, Azienda Ospedaliera, Universitaria Integrata, Verona, Italy. simone.cesaro@aovr.veneto.it., Ljungman P; Division of Haematology, Department of Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden.; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden., Mikulska M; Division of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genova, and Ospedale Policlinico San Martino, Genova, Italy., Hirsch HH; Transplantation & Clinical Virology, Department of Biomedicine, University of Basel, Basel, Switzerland., Navarro D; Microbiology Service, Hospital Clínico Universitario, Instituto de Investigación INCLIVA, Valencia; Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain., Cordonnier C; University Paris Est-Créteil, Paris, France., Mehra V; Department of Haematology, King's College Hospital NHS Foundation Trust, London, United Kingdom., Styczynski J; Department of Paediatric Haematology and Oncology, Jurasz University Hospital, Nicolaus Copernicus University Torun, Collegium Medicum, Bydgoszcz, Poland., Marchesi F; Haematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Pinana JL; Hematology Department, Hospital Clinico Universitario de Valencia; Fundación INCLIVA, Instituto de Investigación Sanitaria, Hospital Clínico, Universitario de Valencia, Valencia, Spain., Beutel G; Department for Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Einsele H; Department of Internal Medicine II, University of Würzburg, Würzburg, Germany., Maertens J; Haematology Department, University Hospitals Leuven, KU Leuven, Leuven, Belgium., de la Camara R; Department of Haematology, Hospital de la Princesa, Madrid, Spain.
Corporate Authors: ECIL-10
Source: Leukemia [Leukemia] 2025 Sep; Vol. 39 (9), pp. 2304-2305. Date of Electronic Publication: 2025 Aug 04.
Publication Type: Letter
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1476-5551
DOI:10.1038/s41375-025-02721-4